跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,200 条关于
“BNP Paribas Asset Management Alts”
全部
29,200
临床试验
18,648
药物
734
机构
267
资讯
9,551
2个月前
ReproNovo Doses First Participant in EU Phase 2 NORDIC Trial of Oral Oxytocin Receptor Antagonist RPN-002 for Embryo Implantation
上个月
Vedanta Biosciences Secures $60 Million to Advance Phase 3 Microbiome Therapy VE303 for Recurrent C. difficile Infection
去年
Stevanato Group Secures €200 Million Financing to Expand Biologics Manufacturing Capacity
去年
Acelyrin's Izokibep Advances in Phase 3 Trials Amidst Analyst Revisions and Institutional Investment
12个月前
Trump Administration Links Acetaminophen to Autism Risk, Triggering Sharp Decline in Kenvue Stock
4个月前
Cellogen Therapeutics Secures $2.4M to Advance Affordable CAR-T Cancer Therapies in India
去年
Siemens to Raise €1.4 Billion Through Strategic Healthineers Stake Sale
4个月前
Angelini Pharma Announces $4.1 Billion Acquisition of Catalyst Pharmaceuticals to Enter US Rare Disease Market
10个月前
Imbria Pharmaceuticals Secures Extended Series B Funding to Advance First-in-Class Cardiovascular Therapy Ninerafaxstat
上个月
Wolfe Research Upgrades Abbott Labs and AbbVie to Outperform Amid In-Line Inflation Data
第 1 页，共 956 页
上一页
下一页
